| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Sales | 2,168,999 | 2,190,398 | ||
| Cost of sales | 1,078,697 | 1,174,769 | ||
| Officer compensation | NaN | 100,000 | ||
| Gross profit | 1,090,302 | 1,015,629 | ||
| Professional fees | 396,929 | 259,566 | ||
| Payroll and related expense | 453,317 | 528,835 | ||
| Selling, general and administrative expenses | 1,048,981 | 1,662,381 | ||
| Impairment loss on goodwill | 130,514 | NaN | ||
| Total operating expenses | 2,029,741 | 2,550,782 | ||
| Loss from operations | -939,439 | -1,535,153 | ||
| Interest expense | 162,180 | 225,476 | ||
| Incentive expense | 24,000 | NaN | ||
| Loss on inventory write-down | 589,177 | NaN | ||
| Other income | 475,745 | 20,703 | ||
| Total other income (expense) | -299,612 | -204,773 | ||
| Loss before provision for income taxes | -1,239,051 | -1,739,926 | ||
| Net loss | -1,239,051 | -1,739,926 | ||
| Preferred stock dividends | 234,438 | 74,446 | ||
| Net loss attributed to common stockholders | -1,473,489 | -1,814,372 | ||
| Basic EPS | -0.02 | -0.04 | ||
| Diluted EPS | -0.02 | -0.04 | ||
| Basic Average Shares | 60,486,788 | 46,763,793 | ||
| Diluted Average Shares | 60,486,788 | 46,763,793 | ||
US NUCLEAR CORP. (UCLE)
US NUCLEAR CORP. (UCLE)